SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-020978 from GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272)

GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272)
Date: May 22, 2024 · CIK: 0001166272 · Accession: 0001493152-24-020978

AI Filing Summary & Sentiment

Date
May 24, 2024
Author
Chief
Form
CORRESP
Company
GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272)

Letter

Re: GENETIC TECHNOLOGIES LIMITED (the “Company”)

May 22, 2024

Via EDGAR

Securities and Exchange Commission

Division of Corporation Finance

F. Street, N.E.

Washington, D.C. 20549

Registration Statement on Form F-1

File No. 333- 279523 (the “Registration Statement”)

Ladies and Gentlemen:

The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 5.00 p.m. (Eastern Time) on May 24, 2024, or as soon thereafter as practicable.

Please contact Darrin M. Ocasio, Esq. of Sichenzia Ross Ference Carmel LLP counsel of the Company, at (212) 930-9700 to provide notice of effectiveness, or if you have any questions or concerns regarding the foregoing.

Very
truly yours,
Genetic
Technologies Limited

Show Raw Text
CORRESP
1
filename1.htm

May
22, 2024

Via
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F. Street, N.E.

Washington,
D.C. 20549

    Re:
    GENETIC
    TECHNOLOGIES LIMITED (the “Company”)

Registration
Statement on Form F-1

File
No. 333- 279523 (the “Registration Statement”)

Ladies
and Gentlemen:

The
Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness
of the Registration Statement so that such Registration Statement will become effective as of 5.00 p.m. (Eastern Time) on May 24, 2024,
or as soon thereafter as practicable.

Please
contact Darrin M. Ocasio, Esq. of Sichenzia Ross Ference Carmel LLP counsel of the Company, at (212) 930-9700 to provide notice of effectiveness,
or if you have any questions or concerns regarding the foregoing.

    Very
                                            truly yours,

    Genetic
    Technologies Limited

    By:
    /s/
    Simon Morriss

    Name:
    Simon
    Morriss

    Title:
    Chief
    Executive Officer

cc:
Darrin M. Ocasio, Esq.